{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:16Z","timestamp":1792788616409,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NHS Tayside Charitable Foundation","award":["533-A03073"],"award-info":[{"award-number":["533-A03073"]}],"id":[{"id":"https:\/\/ror.org\/000ywep40","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sentinel lymph node biopsy (SLNB) using dual tracer techniques remains the gold standard for axillary staging in early breast cancer. However, reliance on radioisotope mapping introduces logistical complexity, cost, and radiation exposure. Indocyanine green (ICG) fluorescence imaging has emerged as a potential single-tracer alternative, but concerns remain regarding its reliability across heterogeneous patient populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective single-centre cohort study was conducted including 300 consecutive SLNB procedures across 292 unique patients using ICG as the sole tracer. The primary endpoints were nodal procedural detection rate and ICG nodal detection rate. Secondary outcomes included: nodal positivity, number of nodes retrieved, operative time, the influence of patient, tumour, and procedural variables. Statistical analysis included linear and logistic regression and correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Procedural nodal detection was achieved in 99.7% (299\/300) of procedures, while ICG fluorescent nodal detection was achieved in 97.7% (293\/300). Median surgeon\u2013pathologist nodal concordance was 100% (IQR 50\u2013100%), with complete count agreement in 50.7% of procedures. Detection was not influenced by age, body mass index (BMI), tumour size, or procedure type. Operative time increased significantly with BMI (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0118) and breast-conserving surgery (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large UK prospective series demonstrates that ICG-only fluorescence guidance is safe, efficient, and reproducible, with high procedural and nodal detection rates. Naked-eye visibility of ICG was observed in a subset of cases, further supporting its practicality. Performance was consistent across surgical procedures and patient BMI. These findings support broader adoption of ICG as a single tracer for SLNB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20316-w","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:25:59Z","timestamp":1785338759000},"page":"10558-10563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ICG-only Sentinel Lymph Node Biopsy in Breast Cancer: A Prospective UK Cohort Demonstrating Consistent Detection Across Patient and Tumour Characteristics\u2014A Follow-on to the INFLUENCE Trial"],"prefix":"10.1245","volume":"33","author":[{"given":"Vassilis","family":"Pitsinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Khitab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kanitkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Elseedawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"10","key":"20316_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Technical outcomes of sentinel lymph node resection and conventional axillary lymph node dissection in clinically node-negative breast cancer. Lancet Oncol. 2007;8(10):881\u20138.","journal-title":"Lancet Oncol."},{"issue":"6","key":"20316_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA."},{"issue":"3","key":"20316_CR3","first-page":"292","volume":"99","author":"GC Wishart","year":"2012","unstructured":"Wishart GC, Benson JR, Pinder SE, Greenberg DC. The impact of sentinel lymph node biopsy on breast cancer management. Br J Surg. 2012;99(3):292\u2013302.","journal-title":"Br J Surg."},{"issue":"8","key":"20316_CR4","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","volume":"15","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15(8):e351\u201362.","journal-title":"Lancet Oncol."},{"issue":"4","key":"20316_CR5","first-page":"524","volume":"42","author":"A Agrawal","year":"2016","unstructured":"Agrawal A, Civantos FJ, Brackstone M, Fallowfield L, Newcombe RG, Mansel RE. Lymphatic mapping and sentinel node biopsy in breast cancer: evolving practice. Eur J Surg Oncol. 2016;42(4):524\u201330.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"20316_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2325\/jbcs.12.211","volume":"12","author":"T Kitai","year":"2005","unstructured":"Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12(3):211\u20135.","journal-title":"Breast Cancer."},{"issue":"1","key":"20316_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1245\/s10434-015-4809-4","volume":"17","author":"T Sugie","year":"2010","unstructured":"Sugie T, Ikeda T, Kawaguchi A, Shimizu A, Toi M. Evaluation of the clinical utility of the indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2010;17(1):44\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"20316_CR8","first-page":"889","volume":"36","author":"C Hirche","year":"2010","unstructured":"Hirche C, Murawa D, Mohr Z, Kneif S, H\u00fcnerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Eur J Surg Oncol. 2010;36(10):889\u201393.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"20316_CR9","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1245\/s10434-011-1566-x","volume":"18","author":"JS Mieog","year":"2011","unstructured":"Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, et al. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescence sentinel lymph node mapping in breast cancer. Ann Surg Oncol. 2011;18(9):2483\u201391.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"20316_CR10","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1245\/s10434-012-2466-4","volume":"19","author":"JR van der Vorst","year":"2012","unstructured":"van der Vorst JR, Schaafsma BE, Verbeek FP, Swijnenburg RJ, Hutteman M, Liefers GJ, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99mTc-nanocolloid for sentinel lymph node detection in breast cancer. Ann Surg Oncol. 2012;19(13):4104\u201311.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"20316_CR11","first-page":"620","volume":"107","author":"BE Schaafsma","year":"2013","unstructured":"Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, et al. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. J Surg Oncol. 2013;107(6):620\u20135.","journal-title":"J Surg Oncol."},{"issue":"3","key":"20316_CR12","first-page":"523","volume":"186","author":"K He","year":"2021","unstructured":"He K, Chi C, Kou D, Huang Y, Zhang Y, Li S. Indocyanine green fluorescence versus radioisotope for sentinel lymph node biopsy in breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2021;186(3):523\u201334.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"20316_CR13","first-page":"1532","volume":"29","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li Y, Zhou Y, Mao F, Lin Y, Guan J, et al. Diagnostic performance of indocyanine green-guided sentinel lymph node biopsy in breast cancer: a meta-analysis. Ann Surg Oncol. 2022;29(3):1532\u201343.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"20316_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.suronc.2015.10.002","volume":"24","author":"V Pitsinis","year":"2015","unstructured":"Pitsinis V, Provenzano E, Kaklamanis L, Wishart GC, Benson JR. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer. Surg Oncol. 2015;24(4):375\u20139.","journal-title":"Surg Oncol."},{"issue":"Suppl 3","key":"20316_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1245\/s10434-017-6186-7","volume":"24","author":"V Pitsinis","year":"2017","unstructured":"Pitsinis V, Wishart GC. Comparison of indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2017;24(Suppl 3):581\u20132.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"20316_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000528155","volume":"64","author":"S Ng","year":"2023","unstructured":"Ng S, Pitsinis V, Elseedawy EH, Brown D, Vinci A, Jones BA, Macaskill EJ. Indocyanine green is a safe and effective alternative to radioisotope in breast cancer sentinel lymph node biopsy regardless of patient body mass index. Eur Surg Res. 2023;64(2):230\u20136.","journal-title":"Eur Surg Res."},{"key":"20316_CR17","volume":"43","author":"R Kanitkar","year":"2025","unstructured":"Kanitkar R, Pitsinis V, Riaz B, Vinci A, Hogg F, Jordan LB. Oncological outcomes and locoregional recurrence after fluorescence guided surgery for axillary staging in early breast cancer: a single UK centre experience. Cancer Treat Res Commun. 2025;43:100922.","journal-title":"Cancer Treat Res Commun."},{"issue":"13","key":"20316_CR18","first-page":"4106","volume":"21","author":"FP Verbeek","year":"2014","unstructured":"Verbeek FP, Troyan SL, Mieog JS, Liefers GJ, Moffitt LA, Rosenberg M, et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Ann Surg Oncol. 2014;21(13):4106\u201312.","journal-title":"Ann Surg Oncol."},{"key":"20316_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2025.110052","volume":"192","author":"P Goldhawk-White","year":"2026","unstructured":"Goldhawk-White P, White KP, Doeksen A, McGoldrick C, Neligan PC, Newman MI, Pitsinis V, Schols RM. Fluorescence imaging with indocyanine green during breast cancer surgery and postmastectomy breast reconstruction: a double systematic review and cost analysis. Surgery. 2026;192:110052.","journal-title":"Surgery."},{"issue":"13","key":"20316_CR20","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1245\/s10434-024-16176-x","volume":"31","author":"V Pitsinis","year":"2024","unstructured":"Pitsinis V, Kanitkar R, Vinci A, Choong WL, Benson J. Results of a prospective randomized multicenter study comparing indocyanine green fluorescence combined with a standard tracer versus ICG alone for sentinel lymph node biopsy in early breast cancer: the INFLUENCE trial. Ann Surg Oncol. 2024;31(13):8848\u201355.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20316-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:24:18Z","timestamp":1792207458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20316-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20316"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20316-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}